9. Bibliography

1. Alcorn K. "Slow progress against HIV" AIDS Action 1995 September-November 20; 2-3

2. Allen U.D., Read S. and Gafni A. "Zidovudine for Chemoprophylaxis after Occupational Exposure to HIV-infected Blood: An Economic Evaluation" Clinical Infectious Diseases 1992;14:822-30

3. Anderson R.M. and May R.M. "Understanding the AIDS epidemic", Scientific American May 1992 p58-66

4. Bloom G. "The Economic Impact of AIDS in Asia", 1991

5. Bozette S.A., Parker R. and Hay J. "A Cost Analysis of Approved Antiretroviral Strategies in Persons with Advanced Human Immunodeficiency Virus Disease and Zidovudine Intolerance", Journal of Acquired Immune Deficiency Syndromes, Vol 7 No. 4 1994 p355-362

6. Broomberg J. and Schopper D. "Global Spending on HIV/AIDS prevention, care and research", Chapter 37 in "AIDS in the World II", 1996, eds. Mann J. and Tarantola D.

7. Conner E.M., Sperling R.S., Gelber R. et al, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group, "Reduction of maternal-infant transmission of human immuno-deficiency virus type 1 with zidovudine treatment", New England Journal of Medicine 1994;331:1173-1180

8. Cosler L.E. and Lambrinos J. "Zidovudine’s Impact on Resource Use by Patients with Symptomatic HIV Illness: A Large Sample Analysis" Inquiry 29: 345-55 Fall 1992

9. Drug and Therapeutics Bulletin (UK) Vol. 35 No.4 April 1997

10. Elhagger S. "Treatment/control of HIV infection" Archives of STD/HIV Research 1993; 7(2): 120-1

11. Floyd K., Wilkinson D. and Gilks C.F. "Community-based directly observed therapy for tuberculosis: An economic analysis", Corporate Communication Division, South African Medical Research Council, Cape Town, South Africa

12. Gable C.B., Tierce J.C., Simison D., Ward D. and Motte K. "Costs of HIV/AIDS at CD4 Counts Disease Stages Based on Treatment Protocols", Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 12 No. 4 p413-420, 1996

13. Gorsky R.D., Farnham P.G., Straus W.L., Caldwell B., Holtgrave D.R., Simonds R.J., Rogers M.F., Guinan M.E. "Preventing Perinatal Transmission of HIV - Costs and Effectiveness of a Recommended Intervention", Public Health Reports July/August 1996 Vol. 111 p 335-341

14. Hay J.W., Osmond D.H., and Jacobson M.A. "Projecting the Medical Costs of AIDS and ARC in the United States", Journal of Acquired Immune Deficiency Syndromes, Vol. 1 No. 5, 1988, p466-485

15. Hellinger F.J. "Forecasts of the Costs of Medical Care for Persons with HIV: 1992-5" Inquiry 29:

356-365, Fall 1992

16. "HIV Physicians forum for the North West Region of the UK", minutes of meeting February 26th 1997

17. Hurley S. et al "The usage and costs of health services for HIV infection in Australia", AIDS 1995: 777-785

18. Karstaedt A.S., Lee T.C.M., Kinghorn A.W.A. and Schneider H. "Care of HIV-infected adults at Baragwanath Hospital, Soweto, Part II. Management and costs of in-patients", South African Medical Journal 1996; 86: 1490-493

19. Kinghorn A.W.A., Lee T.C.M., Karstaedt A. S., Khuonane B., Schneider H. "Care of HIV-infected adults at Baragwanath Hospital, Soweto, Part I. Clinical Management and costs of out-patient care", South African Medical Journal 1996; 86: 1484-1489

20. Klopper J.M., Myers J.E., Ehrlich R., McIntyre D., Chetty K., Weir G., Hoffman M., Cooper D., London L. "AIDS and the social irresponsibility of the insurance industry", South African Medical Journal, 1993, September 83(9): 690

21. Laws M. "International Funding of the Global AIDS strategy: Official Development Assistance", Chapter 35 in "AIDS in the World II", eds. Mann J. and Tarantola D., 1996

22. Makadon H.J., Seage G.R., Thorpe K.E. and Fineberg H.V. "Paying the medical cost of the HIV epidemic: a review of policy options" Journal of Acquired Immune Deficiency Syndromes 1990; 3(2): 123-33

23. Mansergh G., Haddix A., Steketee R.W., Nieburg P.I., Dale J., Simonds R.J., Rogers M. "Cost-effectiveness of Short-Course Zidovudine to Prevent Peri-natal HIV Type 1 Infection in a Sub-Saharan African Developing Country Setting", JAMA July 10 1996 Vol. 276 No.2 p139-145

24. Martin A. "The cost of HIV/AIDS Care", Chapter 36 in "AIDS in the World II", eds. Mann J. and Tarantola D., 1996

25. Mauskopf J.A., Paul J.E., Wichman D.S., White A.D., and Tilson H.H. "Economic Impact of Treatment of HIV-Positive Pregnant Women and Their Newborns with Zidovudine", JAMA July 10 1996 Vol. 276 No.2 p133-138

26. McDermott J., Williamson E., Wallace E., Thomas M.G., Ellis-Pegler R.B. "Hospital outpatient costs for patients with HIV infection" New Zealand Medical Journal February 1991 p43-44

27. MMWR Vol.45 No. 22, 1996 "Notice to Readers" entitled "Update: Provisional Public Health Service Recommendations for Chemoprophylaxis after Occupational Exposure to HIV" p468-472

28. Montaner J.S.G., Schechter A., McLeod et al "The impact of zidovudine on AIDS-related hospital admissions: how long does the honeymoon last?" Paper presented at the fifth international conference on AIDS, Montreal, 1990

29. Moore R.D., Hidalgo J., Bareta J.C. and Chaisson R.E. "Zidovudine Therapy and Health Resource Utilization in AIDS" Journal of Acquired Immune Deficiency Syndromes, Vol. 7 No. 4 1994

30. Murphy C. and Montaner J.S. "Anti-retroviral therapy" p291-310 in SIDA: Epidemiologia, Diagnostico, Tratamiento y Control de la Infeccion VIH" ed. Sanchez J. et al, 1994

31. Oddone E.Z., Cowper P., Hamilton J.D., Matchar D.B., Harrigan P., Samsa G., Simberkoff M., Feussner J.R. "Cost-effectiveness analysis of early zidovudine treatment of HIV-infected patients", BMJ Vol 307 1993 p1322-1325

32. Oppenheimer G.M. and Padgug R.A. "AIDS: the risks to insurers, the threat to equity", Hastings Cent. Report, 1986 Oct; 16(5): 18-22

33. Piot P. "AIDS: a global response" Science 1996 June 28th 272: 1855

34. Roper W.L. and Winkenwerder W. "Making fair decisions about financing care for persons with AIDS" Public Health Reports 1988 May/June; 103(3): 305-8

35. Sabatier R., Foreman M., Tinker J. and Radlett M. "AIDS and the Third World", Panos Institute, London 1989

36. Santos B., Beck E.J. and Peixoto M.F. "Survival and medical intervention in Southern Brazilian AIDS patients", International Journal of STD and AIDS, Vol 5 July/August 1994, p279-283

37. Schitovsky A.A., Cline M.W., and Abrams D.I. "Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 months" Journal of Acquired Immune Deficiency Syndromes, 1990, p904-912

38. Schulman K.A., Lynn L.A., Glick H.A., Eisenberg J.M. "Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection" Annals of Internal Medicine Vol. 114 No.9 1991 p799-803

39. Solomon D.J. and Hogan A.J. "HIV Infection Treatment Costs Under Medicaid in Michigan" Public Health Reports July-August 1992 Vol. 107 No. 4 p461-469

40. Wilkinson D. et al "Rapid HIV testing strategies", AIDS 1997 Vol. 11 No. 3

41. World Bank, World Development Report, 1993